$INTT

InTest (INTT) Q2 2026 Earnings Call Transcript

InTest (INTT) reported Q2 2026 revenue of $35.3M, up 25.5% YoY, with semi orders $12.0M (+64% YoY) and backlog $45.4M (+19.8% YoY). Full-year guidance raised to $135M-$140M. Gross margin was 40.5% and adjusted EBITDA $2.2M. CFO cited a material weakness at Alfamation.

Original reporting
Published Aug 11, 2026, 3:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 4:08 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
InTest (INTT) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$INTTNeutralMed
01

Why it matters

Traders can reprice the stock on the combination of raised FY revenue guidance, Q3 revenue and gross margin guidance, and the risk overhang from a material weakness at the Alfamation division.

02

Market read

Guidance raises and backlog growth support a demand recovery narrative, while gross margin decline and internal-control remediation risk can cap the multiple.

03

What to watch

The Alfamation internal control material weakness and remediation timeline could create near-term operational friction, potentially affecting delivery schedules and customer acceptance testing.

Relevance 8/10Novelty 8/10Timing: pre-market today, following the Q2 2026 earnings call and guidance update

Background

InTest reported Q2 2026 results with a mix shift toward non-semi markets and discussed semiconductor back-end capacity dynamics.

Company-level read

Ticker impact

$INTTNeutralMedium confidence
Context

InTest raised full-year revenue guidance to $135 million to $140 million and guided Q3 revenue to $33 million to $35 million.

Expected impact

Likely positive bias on guidance, with volatility risk around internal-control remediation and mix-driven gross margin.

Evidence & confidence

The article discloses multiple fresh datapoints (raised FY guide, Q3 guide, backlog growth, and a newly cited material weakness) that can move expectations, but it is still an earnings-call transcript without explicit consensus comparisons.

Market effects

Signals potential recovery in semiconductor back-end testing demand while highlighting margin sensitivity to automotive project mix.

Defense/Aerospace orders growth points to continued U.S. DoD procurement tailwinds.

Limited direct global macro linkage; mostly company-specific demand and execution updates.

Counterpoint

The raised revenue outlook may be driven by timing and mix shifts (higher-contribution revenue pushed into Q3) rather than durable margin expansion, so upside could fade if gross margin fails to hold.

Key entities

  • InTest Corporation

    Reported Q2 2026 results, raised full-year revenue guidance, and disclosed a material weakness at the Alfamation division.

  • Rich Rogoff

    CEO who discussed semiconductor back-end cycle capacity and shipment timing.

  • Duncan Gilmour

    CFO who cited the Alfamation material weakness and provided guidance details.

Related articles

$INTTMed

INTEST CORP (INTT): Results of Operations and Financial Condition

INTEST CORP (INTT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEWS RELEASE 804 EAST GATE DRIVE, SUITE 200, MOUNT LAUREL, NJ 08054 FOR IMMEDIATE RELEASE InTest Reports Strong Second Quarter 2026 Revenue of $35.3 Million EPS of $0.04 and Adjusted EPS (Non-GAAP) of $0.09 • Second quarter revenue up 25.5% year-over-year, driven lar

$INTTMed

Why is inTest stock climbing today?

inTest Corp (INTT) shares rose 1.7% in pre-open trading after Northland upgraded the stock to “outperform” from “market perform” and set a $15.00 price target. Northland cited inTest’s preliminary Q2 2026 revenue estimate of about $35M and raised full-year 2026 revenue guidance to $135M-$140M, while noting a planned 220 bps gross margin reduction.

$INTTMed

INTEST CORP (INTT): Results of Operations and Financial Condition

INTEST CORP (INTT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEWS RELEASE 804 EAST GATE DRIVE, SUITE 200, MOUNT LAUREL, NJ 08054 FOR IMMEDIATE RELEASE InTest Reports Preliminary Second Quarter 2026 Results • Second Quarter Revenue Estimated to be Approximately $35 Million • Second Quarter Gross Margin Estimated to be Approxima

$GCOMed

102-year-old mall retailer quietly closes 25 stores

Genesco (GCO) closed 25 stores, including 17 Journeys locations, in Q2 fiscal 2027, per its earnings release. Net sales fell 3% YoY to $530M, with comparable sales down 1%. The company is shifting away from malls and remodeling stores to boost sales, with 4.0 Journeys stores showing 25% higher sales.

$EQIXMedAI 8/10

Equinix Is Doubling Down on AI Data Centers. How to Play EQIX Stock Here

Equinix (EQIX) reported Q2 revenue of $2.63B, up 16% YoY, beating estimates. AFFO was $11.78/share, up 19% YoY. The company raised full-year guidance and unveiled a multi-year growth plan. EQIX stock has surged 34% over the past year and offers a 1.98% dividend yield. Analysts rate it a 'Strong Buy' with an average price target of $1,232.19.